Skip to Main Content

Paper Details

Reduction of αSYN Pathology in a Mouse Model of PD Using a Brain-Penetrating Bispecific Antibody.
Pharmaceutics
12
2022
L61, Mouse, PD, Parkinson's disease, RmAbSynO2, SYN, SYN antibodies, TBS-T, alpha-synuclein, mice, scFv8D3, transferrin receptor
Author NameAffiliation
Eliezer Masliah
Eliezer Masliah
Martin IngelssonUppsala University
Martin IngelssonKrembil Brain Institute, University Health Network
Martin IngelssonUniversity of Toronto
  • 1 - 5

Datasets

Release 1.2